e4e6 Consulting

We support your corporate development & internationalisation
We Are Not Consultants, We are Insiders !! We Create Value by Turbocharging your Team

[e4e6 Consulting @e4e6Consulting]

En France, les autorités de santé (@HAS_sante ) ouvrent la voie au remboursement du @Wegovy dans des cas d’obésité sévère (BMI > 35)

Cool!! Et maintenant on discute du prix? 😇

#obesité #Wegovy #cardiovasculaire #diabete #T2DM

https://t.co/QlZOt7Xmz7

[e4e6 Consulting @e4e6Consulting]

Excellent edito dans @LesEchos ce matin.
En nous, en #Europe, on fait quoi? On régule pendant que les Chinois copient (en fait, ils copient de moins en moins et innovent de plus en plus).

#Musk @elonmusk #biotech #medtech #Innovation

https://t.co/uemvZhwVSg

[e4e6 Consulting @e4e6Consulting]

New Article Published on our website: @RobertKennedyJras U.S. Secretary of Health: An Additional Threat to #Biotech Investment?

https://t.co/06aMdSNsl6

#medtech #VentureCapital #innovation #healthcare

[e4e6 Consulting @e4e6Consulting]

@learnbiotech it would be interesting to have a updated PoS from one step on an other

[Biotech Investor @learnbiotech]

Incorporating Probability of Success (PoS) is a unique aspect of #biotech valuation investors must be aware of.

It tries to factor development risk into revenue and cost assumptions.

Here is a table of PoS values:

#learnbiotechinvesting #investing #BiotechPrometheus

[e4e6 Consulting @e4e6Consulting]

Boundaries blur between business & politics: for #CEOs, Understanding geopolitical dynamics is no longer a luxury for CEOs: it's a must.
Read our lastest insight

#Geopolitics #USElection2024 #internationalexpansion

https://t.co/l4vZBcTRY1

[e4e6 Consulting @e4e6Consulting]

@sanofi / #Doliprane drama: are the politicians and media concerned about the right thing?

Concern should be : Why is @Bpifrance pouring money there? This should raise concerns from the ecosystem as start up are dying daily.

#biotech

https://t.co/IV2STctsrM

[e4e6 Consulting @e4e6Consulting]

@sanofi / #Doliprane : drama, are politicians and media concerned about the right thing?

Concern should be: Why is @Bpifrance pouring money there? This should raise concerns from the ecosystem as start up are dying daily...

#biotech #Innovation

https://t.co/IV2STctsrM

[e4e6 Consulting @e4e6Consulting]

@ImplicityHealth' s @HAS_sante approval marks a strategic shift in #telemedicine. AI-driven, universal platforms will be key to managing #chronicdiseases With better outcomes & lower costs, this sets the stage for future healthcare innovations.
#MEDTECH

https://t.co/8VXJ9dPGLs

[e4e6 Consulting @e4e6Consulting]

Our passion for #Japan runs deep. Today, we’re thrilled to announce the launch of our Japanese-language page website! 🇯🇵

An exciting step in making it easier for our Japanese clients to access our expertise & learn how we can help them succeed in EU

https://t.co/fK2CFUiIHo

[e4e6 Consulting @e4e6Consulting]

@LesEchos front page today: 2 major threats to healthcare French Sovereignty
Slashing CIR: a direct threat to the nation's long-term innovation & economic independence.
Paracetamol? Did not @EmmanuelMacron said we want to be self sufficient 🤨
#innovation #CIR #Paracetamol

[e4e6 Consulting @e4e6Consulting]

From Soft Power to #startups : How #Japan Captivates French #entrepreneurs
https://t.co/G6OUGbSY0i
Please read this interesting perspective just freshly published on our website.

#entrepreneurship #internationalization

[Biotech Investor @learnbiotech]

Investors should be aware of where the competition is in development

Here's the expected launch timeline of the major late-stage #obesity drugs

$LLY & $NVO can expect first competitor approval in 2026

#learnbiotechinvesting #biotech #investing #BiotechPrometheus

[e4e6 Consulting @e4e6Consulting]

A very interesting perspective on #Investment in #Oncology

#biotech #Innovations

[Biotech Investor @learnbiotech]

Investors must consider patient populations to assess revenue opportunity, which implies valuation
In general, higher response rates (ORR) are in smaller patient populations
The outsized opportunities are in the top right of the graph

#learnbiotechinvesting #BiotechPrometheus

[e4e6 Consulting @e4e6Consulting]

@e4e6Consulting is happy to announce that it is now part of @FranceBiotech

We are looking forward to meet new people and contribute to the success of the French #HealthTech ecosystem.

#Biotech #medtech #esanté #ehealth #Healthtech

[e4e6 Consulting @e4e6Consulting]

BREAKING NEWS: @Biogaran will remain French. @ServierPharma will not divest it #generic drugs affiliate!! This is great news for #France, for #Europe, and ultimately for the #patients!!

#pharmaceuticals #genericdrugs

https://t.co/NI74vNxGAn

[e4e6 Consulting @e4e6Consulting]

Immuno-oncology has a lot more to bring to patients but #pharmaceutical industry and #investors have to believe in it and support...

#BiotechStartups #biotechs #Cancer #Oncology #Innovations

[Ned Pagliarulo @NedPagliarulo]

10 years ago today, Keytruda became the first PD1 inhibitor approved in the US.

In a long read that's well worth your time, @ByJonGardner traces how, over the past decade Keytruda, Opdivo and their cousins have changed oncology:

https://t.co/JNrZzMVo9O

[e4e6 Consulting @e4e6Consulting]

Making the French CIR (Research Tax Credit) more difficult & cancelling the support to young #PhD employement? It is really what the new French to-be-appointed governement want to insure French research remains at the top?

#biotech #MedTech #Innovation

https://t.co/3Q0Imv1lz5

[e4e6 Consulting @e4e6Consulting]

As part of the launch of its updated website, e4e6 has added a new section: #publication
Food for thoughts in the fields of #international expansion, #biotech, #MEDTECH , #Fintech , #videogames and much more to come. Stay Tuned!!

https://t.co/G6OUGbSY0i

[e4e6 Consulting @e4e6Consulting]

Our new website is launched!
If you need help for #international expansion, #strategic, #operational or #transaction support, please our site and contact us to discuss your needs

#Biotech #medtech #ehealth #fintech

https://t.co/x8Rb3izjGu